Trade Replimune - REPL CFD

Trading Conditions

• Type: CFD
• Spread: 0.09
• Long position overnight funding adjustment: -0.02151%
• Short position overnight funding adjustment: -0.00071%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 7.15
• Open: 7.42
• 1-Year Change: -28.17%
• Day's Range: 7.42 - 7.81

Trade Replimune - REPL CFD

What is Replimune (REPL)?

Replimune Group, Inc. is a biotechnology company focused on the development of oncolytic immunotherapies for the treatment of cancer. The company’s approach involves engineered viruses designed to selectively infect and destroy tumor cells while stimulating an immune response against cancer. Replimune's pipeline includes candidates targeting various solid tumors, employing viral vectors modified to enhance therapeutic efficacy and safety. The company operates within the immuno-oncology sector, aiming to harness the body's immune system to improve cancer treatment outcomes. Replimune collaborates with research institutions to advance its clinical programs.

Replimune Stock Price Today: Live Overview

The price today is shaped by current market trends with Replimune priced at $7.7. The session's price range lies between $7.17 and $7.83, with a daily movement of +5.9972%.

FAQ: Replimune (REPL)

What is the current price of REPL stock?

The stock price is $7.7.

Does REPL pay dividends?

Replimune does not pay dividends.

Does REPL have a formal corporate presence or regional headquarters in the UAE?

Replimune operates in the UAE through distributors without an official office or subsidiary.

What is REPL best known for?

Replimune is most famous for its oncolytic immuno-oncology therapies.

What assets are typically shown together with REPL?

Commonly shown alongside REPL: Direxion Daily MSCI Mexico Bull 3x Shares, Koninklijke KPN, Telefonica